April 2 () - AstraZeneca said on Thursday that a combination treatment with its cancer drug Imfinzi showed significant ...

The approval also covers Keytruda SC, known in the US as Keytruda Qlex (pembrolizumab and berahyaluronidase alfa-pmph).

Combination therapy is essentially a one-two punch at cancer—sometimes with multiple punches. For people with lung cancer, it ...

The phase 3 study, known as Neo-Healer or KN026–004, was an open-label, multicenter trial that randomly assigned ...

Researchers at the University of Colorado (UC) Denver, Anschutz Medical Campus, have discovered a novel combination treatment strategy that could offer new hope to ovarian cancer patients who stop ...

Add Yahoo as a preferred source to see more of our stories on Google. A major international trial finds that adding niraparib to standard prostate cancer therapy delays disease progression. (CREDIT: ...

OPDIVO is a prescription medicine used in combination with YERVOY as a first treatment to treat adults with cancer of the ...

Cancer treatment has made remarkable strides. New drugs and technologies have changed outcomes for many patients, turning some once-fatal diagnoses into manageable conditions. Yet despite these ...

A Rutgers Cancer Institute study in Cell Reports Medicine promises help with both those problems. It identifies a protein ...

A person walks past blue flags placed on the National Mall near the Capitol as part of an effort to advocate for funding and research into fighting colorectal cancer, Wednesday, March 12, 2025, in ...

The FDA has approved Lifyorli (relacorilant) plus Abraxane for certain platinum‑resistant ovarian cancer patients, offering a ...